PRINC Suvarnabhumi Hospital Partners with Institut Jantung Negara to Enhance Cardiovascular Care in the Region

July 30, 2024 – PRINC Suvarnabhumi Hospital, part of Principal Healthcare and Principal Capital Public Company Limited (PRINC), has signed a Memorandum of Understanding (MOU) with Institut Jantung Negara (IJN), a leading center for cardiovascular and thoracic care in Malaysia. This collaboration aims to elevate cardiovascular care standards in the region. A traditional Thai welcome was given to the IJN delegation by Athiwat Noiprasit, M.D., Assistant Managing Director of Principal Capital Public Company Limited., with representatives from both parties participating in the signing ceremony. The attendees included Somkid Udomkijmongkol, M.D., Director of PRINC Suvarnabhumi Hospital, Ms.Sudamas Boonwan, Director of General Management of PRINC Suvarnabhumi Hospital, Dato' Akmal Arief, Deputy Chief Executive Officer of Institut Jantung Negara (IJN), and Dr. Farina Salleh, Director of Quality at Institut Jantung Negara (IJN), held in the PanSuk Meeting Room, 5th floor of PRINC Suvarnabhumi Hospital, Samut Prakan Province.

Somkid Udomkijmongkol, M.D., Director of PRINC Suvarnabhumi Hospital, stated, “The collaboration with Institut Jantung Negara (IJN) is a significant step for PRINC Suvarnabhumi Hospital, committed to becoming a leader in cardiovascular health care in the region. Partnering with an institution with expertise and experience in cardiology and thoracic surgery like IJN supports our medical capabilities and cooperation, enabling us to offer comprehensive and modern treatment approaches to our patients. This collaboration will also help elevate the standard of cardiovascular care in Thailand to international levels.”

Dato' Akmal Arief, Deputy Chief Executive Officer of Institut Jantung Negara (IJN), remarked, “We are greatly honored to partner with PRINC Suvarnabhumi Hospital. This collaboration aligns with IJN's vision of becoming a global center of excellence in integrated cardiovascular and thoracic care. By exchanging knowledge and technology, we can develop new innovations to enhance heart disease treatment and provide equal access to quality care for patients in Thailand.”

The primary goal of this MOU is to exchange medical knowledge and technology to improve the effectiveness of heart disease treatment. It includes joint seminars and shared research to build academic networks, enhance the capabilities of doctors, nurses, and medical staff, and foster international medical partnerships. This collaboration also opens opportunities for the development and expansion of medical care in the future.